Combair

Combair is an inhalation medication combining beclometasone dipropionate and formoterol fumarate dihydrate. It is used for managing asthma and chronic obstructive pulmonary disease (COPD). This combination therapy helps control symptoms and improve breathing.

Combair is primarily used for the maintenance treatment of asthma and COPD. The medication works by reducing inflammation in the airways and relaxing the muscles around them, making it easier to breathe. It is often prescribed for individuals who require both an inhaled corticosteroid and a long-acting beta-agonist for effective symptom management.

Common effects of Combair may include a decrease in asthma or COPD symptoms such as wheezing, shortness of breath, and coughing. Some users may experience mild side effects like throat irritation or hoarseness. It is important to use the medication as directed by a healthcare professional to minimize potential side effects.

Combair should be used with caution in individuals with certain medical conditions, such as heart disease or diabetes. It is important to follow the prescribed dosage and administration instructions. Regular monitoring by a healthcare professional is recommended to ensure the medication's effectiveness and safety.

Combair may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare professional about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol should be discussed with a healthcare professional.